SPATIOTEMPORAL CONTROL FOR PROLIFERATION AND DIFFERENTIATION OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN THE REPAIR OF ARTICULAR CARTILAGE DEFECTS
T. Mimura, S. Imai, K. Nishizawa, K. Mitsuhiko, K. Ando, N. Okumura, Y. Matsusue. Shiga University of Medical Science, Shiga, JAPAN Purpose: In the previous study, we revealed that the concentrationgradient collagen gel effectively recruited the bone marrow-derived mesenchymal stem cells (MSCs) to the osteochondral defects in the rabbit knee via haptotaxis, and enhanced the osteochondral repair (OARSI, Miami, 2007) . In this study, we investigated the effectiveness of timely administration of bone morphogenetic protein-2 (BMP-2) to the MSCs which were recruited to the defects by collagen scaffold. Methods: The concentration-gradient collagen scaffold that we previously reported were implanted to the full-thickness cartilage defects and recombinant human BMP-2 was supplied into the knee joint during one week by osmotic pumps. Four experimental groups were assigned: BMP-2 was immediately administrated during 1 week after operation (group 1), BMP-2 was administrated during 1 week from one week postoperatively (group 2), and BMP-2 was administrated during 1 week from two weeks postoperatively (group 3), and saline only (control, group 4). Rabbits were sacrificed at 1, 2, 3, 4 and 8 weeks postoperatively, and Bromodeoxyuridine (BrdU) positive cells were enumerated and histological grading score were counted. Results: Enumeration of the BrdU positive cells demonstrated that initial BMP-2 (group 1) increased the number of proliferating cells during the 1st week, and promoted the differentiation of the proliferating cells during the 2nd week. The histological score of group 1 was superior as compared with other groups at the 8 weeks postoperatively. Conclusions: In combination with the haptotactic recruitment of the MSCs, timely administration of BMP-2 clearly enhanced the proliferation and differentiation of the MSCs. This spatiotemporal control of MSC proliferation and differentiation is warranted to contribute to the successful regeneration of the full-thickness cartilage defects. Purpose: Osteoarthritis (OA) is associated with advancing age and/or traumatic intra-articular injuries. NSAIDs are commonly prescribed to help reduce pain and improve function, but these drugs do not reverse the degenerative changes of OA. The administration of compounds such as glucosamine (GlcN) and chondroitin sulphate (CS) have protective effects on chondrocytes. Although these compounds enhance extracellular matrix (ECM) production by healthy chondrocytes, it is still unclear what their effect is on OA chondrocytes. The aim of this study was to determine whether GlcN has a beneficial effect on OA chondrocytes when cultured in vitro in 3D hydrogels. The inflammatory response and ECM formation capacity of OA chondrocytes were investigated with varying GlcN concentration. An in vivo OA model was developed in rats to detect degenerative changes at 4 and 8 weeks.
